股票 › INDV
印迪维奥 INDV
美股市值排名 #2217
$0.00 +$0.91 (+2.57%)
休市 · Nov 3, 3:20 am ET · 最新盘后价 $36.41 +0.36%
开盘$0.00
昨收$0.00
当日区间$0.00 – $0.00
成交量0.00
市值$4.28B
市盈率（TTM）10.2
股息率–
INDV 相关新闻
匹配 Indivior 或代码 INDV 的头条新闻，按最新排序。
- Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating
- Barclays Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $43 负面
- Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Announces Target Price $53
- H.C. Wainwright Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $48
- Barclays Initiates Indivior(INDV.US) With Buy Rating, Announces Target Price $46
- Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $59 正面
- Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $54 正面
- Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $50
- Earnings Flash (INDV) Indivior Pharmaceuticals, Inc. Posts Q3 Adjusted EPS $1.32 per Share, Vs. FactSet Est of $1.06
- GUIDANCE: (INDV) Indivior Expects 2026 Net Revenue Range $1.30B to $1.37B, Vs. FactSet Est of $1.33B
- Barclays Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $45 正面
- Indivior: Indivior Pharmaceuticals, Inc. - Anticipated Cash Distribution Option Symbol: INDV
- Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Announces Target Price $50
- Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $50 正面
- H.C. Wainwright Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $48 正面
暂无评论——快来第一个聊聊 INDV。
登录后参与讨论。